FDA To Launch Pharmacogenomics Website, Issue Guidance In March
This article was originally published in The Gray Sheet
Executive Summary
FDA will publish its final guidance on voluntary pharmacogenomic data submissions in March, Office of Clinical Pharmacology & Biopharmaceutics Director Lawrence Lesko told the Drug Information Association meeting in Lisbon, Portugal March 9